Akums Drugs gest patent for oral suspension of Hydroxyurea for Sickle Cell Disease
Pharma major Akums Drugs and Pharmaceuticals has secured a patent for its Room Temperature Stable Oral Suspension of Hydroxyurea, a breakthrough formulation aimed at managing Sickle Cell Disease (SCD). Sickle Cell Disease, a...
Akums Drugs launches first stable oral suspension for Sickle Cell Disease
Major Pharma company Akums Drugs announced the launch of India’s first stable oral suspension for Sickle Cell Disease. This innovative product is thoughtfully accompanied by oral syringes for precise dosage...
Over 1 crore people screened for sickle cell disease under national mission
More than one crore people have been screened for sickle cell disease under the National Sickle Cell Anaemia Elimination Mission since its launch by Prime Minister Narendra Modi in July last year. The programme aims to...
India launches locally-made rare disease drugs, cost slashed by hundred-fold
The Union Health Ministry on Friday said that the four made-in-India drugs for rare diseases have been launched in the country. As the drugs for rare disease are being imported at expensive cost, these made-in-India drugs...
Sickle Cell Disease is multi-sectoral mission leveraging community mobilization, stakeholder collaboration: Dr. V K Paul
Sickle Cell Disease is a multi-sectoral mission leveraging community mobilization and stakeholder collaboration, said Dr. V K Paul, Member Health, Niti Aayog while addressing the Post Budget Webinar ‘Leaving No Citizen...
Trending
© 2024
|
medlarge.com